English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT
Add to Basket
  Local TagsRelease HistoryDetailsSummary

Released
Journal Article

The BCG replacement vaccine VPM1002: from drawing board to clinical trial

MPS-Authors
/persons/resource/persons81969

Kaufmann,  Stefan H. E.
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

/persons/resource/persons81894

Gengenbacher,  Martin
Department of Immunology, Max Planck Institute for Infection Biology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Kaufmann, S. H. E., Cotton, M. F., Eisele, B., Gengenbacher, M., Grode, L., Hesseling, A. C., et al. (2014). The BCG replacement vaccine VPM1002: from drawing board to clinical trial. Expert Review of Vaccines, 13(5), 619-630. doi:10.1586/14760584.2014.905746.


Cite as: https://hdl.handle.net/11858/00-001M-0000-001A-160C-3
Abstract
There is no abstract available